Symbol | Exchange | Currency |
|---|
Investing.com - Edesa Biotech (NASDAQ: EDSA) reported first quarter EPS of $-0.395, in line with the analyst estimate of $-0.395. Revenue for the quarter came in at $0.00 versus...
Investing.com – U.S. equities were mixed at the close on Tuesday, as gains in the Oil & Gas, Healthcare and Technology sectors propelled shares higher while losses in the Telecoms,...
Investing.com – U.S. equities were lower at the close on Monday, as losses in the Oil & Gas, Basic Materials and Technology sectors propelled shares lower. At the close in NYSE,...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Edesa Biotech, Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on inflammatory and immune-related diseases. The Company's two lead product candidates, EB05 and EB01, are in later stage clinical studies. EB05 is a monoclonal antibody therapy, developing as a treatment for acute respiratory distress syndrome (ARDS), a life-threatening form of respiratory failure. ARDS can be caused by viral diseases, including Covid-19, bacterial pneumonia, sepsis, chest injury and other causes. Specifically, EB05 inhibits toll-like receptor 4 (TLR4), an immune signaling protein and an important mediator of inflammation that has been shown to be activated by SARS-COV2 as well as other respiratory infections, such as influenza. In addition to EB05, the Company is also developing an sPLA2 inhibitor, designated as EB01, as a topical treatment for chronic allergic contact dermatitis (ACD), a common, potentially debilitating condition and occupational illness.
| Average | 13.000 (+862.963% Upside) |
| High | 16.000 |
| Low | 10.000 |
| Price | 1.350 |
| No. of Analysts | 3 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 4.94 | 4.94 | 4.80 | +0.180 | +3.78% | 15.30M | Sydney | |||
| 195.23 | 195.745 | 191.55 | +4.900 | +2.57% | 849.29K | Sydney | |||
| 7.94 | 7.98 | 7.85 | +0.01 | +0.13% | 1.34M | Sydney | |||
| 0.021 | 0.022 | 0.021 | -0.002 | -8.70% | 1.25M | Sydney | |||
| 0.049 | 0.049 | 0.049 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 0.355 | 0.355 | 0.355 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 0.49 | 0.49 | 0.485 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 16.70 | 16.83 | 16.45 | -0.570 | -3.30% | 5.06M | Sydney | |||
| 25.79 | 25.98 | 25.72 | +0.130 | +0.51% | 5.19M | Sydney | |||
| 28.40 | 28.48 | 27.80 | +0.22 | +0.78% | 273.60K | Sydney | |||
| 0.045 | 0.046 | 0.044 | +0.001 | +2.27% | 5.46M | Sydney | |||
| 0.021 | 0.021 | 0.019 | 0.00 | 0.00% | 0.00 | Sydney | |||
| 0.022 | 0.023 | 0.022 | 0.00 | 0.00% | 837.47K | Sydney | |||
| 1.18 | 1.185 | 1.16 | +0.005 | +0.43% | 1.50M | Sydney | |||
| 0.74 | 0.76 | 0.725 | +0.015 | +2.07% | 131.16K | Sydney |